EmCyte’s Circles-Based Real-World Evidence Program Delivers Clinically and Statistically Significant Results
April 1, 2024
EmCyte’s Circles-Based Real-World Evidence Program Delivers Clinically and Statistically Significant Results
EmCyte Corporation is a world leader in the design, manufacture, and distribution of integrated systems for platelet rich plasma, bone marrow cell concentrate, adipose concentrate, bone marrow harvesting and PRP analysis. EmCyte also supports Gulf Coast Biologics, led by Peter A. Everts, PhD, FRSM. GCB is a separate entity dedicated to the education and training of doctors from around the world in the evidence-based clinical use of biologics-based therapies.
For well over a year, EmCyte and GCB have been using the Circles platform to develop clinically and statistically significant datasets supporting various biologics treatments for knee and shoulder pathologies. (These have included patients presenting with bi-lateral conditions.)
The Circles program has involved 10 clinical investigators in North America, collected detailed clinical interventional data and long-term outcomes up to one year. At the recent annual meeting of the Interventional Orthobiologics Foundation, Imran Siddiqui, M.D. of ROSM delivered a presentation reflecting statistical as well as clinical significance based on the real-world data collected by GCB Knee Circle.
As the EmCyte Circles program continues to expand, many more clinicians in North America and Europe will have access to, and be able to participate in, efficient yet powerful studies which will lead to clinical decision support and new standards of care for a variety of musculoskeletal pathologies.
EmCyte’s Circles-Based Real-World Evidence Program Delivers Clinically and Statistically Significant Results
April 1, 2024
EmCyte Corporation is a world leader in the design, manufacture, and distribution of integrated systems for platelet rich plasma, bone marrow cell concentrate, adipose concentrate, bone marrow harvesting and PRP analysis. EmCyte also supports Gulf Coast Biologics, led by Peter A. Everts, PhD, FRSM. GCB is a separate entity dedicated to the education and training of doctors from around the world in the evidence-based clinical use of biologics-based therapies.
For well over a year, EmCyte and GCB have been using the Circles platform to develop clinically and statistically significant datasets supporting various biologics treatments for knee and shoulder pathologies. (These have included patients presenting with bi-lateral conditions.)
The Circles program has involved 10 clinical investigators in North America, collected detailed clinical interventional data and long-term outcomes up to one year. At the recent annual meeting of the Interventional Orthobiologics Foundation, Imran Siddiqui, M.D. of ROSM delivered a presentation reflecting statistical as well as clinical significance based on the real-world data collected by GCB Knee Circle.
As the EmCyte Circles program continues to expand, many more clinicians in North America and Europe will have access to, and be able to participate in, efficient yet powerful studies which will lead to clinical decision support and new standards of care for a variety of musculoskeletal pathologies.